Genetic Engineering & Biotechnology NewsIt’s been no secret that screening methods to detect prostate cancer have been woefully lacking and largely inconsistent with respect to the results they provide. Yet, with the rise in validated biomarkers and advanced diagnostics coupled with next Prostate cancer blood test ‘helps target treatment’ ..
Abiraterone: Now Upfront for Advanced Prostate Cancer?
MedscapeCHICAGO — New results with first-line use of abiraterone (Zytiga, Janssen) are set to transform the upfront treatment of advanced prostate cancer “practically overnight,” based on results of the STAMPEDE and LATITUDE trials presented here at the Drug Extends Lives of Patients With Advanced Prostate Cancer: Studies ..
MSKCC Researchers Debut High-Intensity Liquid Biopsy Method Developed With Grail
The GuardianCHICAGO (GenomeWeb) – At this week’s annual meeting of the American Society of Clinical Oncology, researchers from Memorial Sloan Kettering Cancer Center shared new data on a method that they highlighted as a first step toward a test that can detect …New technology dives deep into the cancer genome ..
Drug Extends Lives of Patients With Advanced Prostate Cancer: Studies
HealthDaySATURDAY, June 3, 2017 (HealthDay News) — Men with advanced prostate cancer might be able to avoid chemotherapy by taking an additional anti-testosterone pill along with standard hormone therapy, a pair of new clinical trials show. The drug …Early use of J&J’s Zytiga extends prostate cancer survival ..